Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Tenofovir

🥰Excellent
Catalog No. T1649Cas No. 147127-20-6
Alias TDF, PMPA, GS 1278

Tenofovir (GS 1278) is an adenine analog REVERSE TRANSC-RIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B. It is used to treat HIV INFECTIONS and CHRONIC HEPATITIS B, in combination with other ANTIVIRAL AGENTS, due to the emergence of ANTIVIRAL DRUG RESISTANCE when it is used alone.

Tenofovir

Tenofovir

🥰Excellent
Purity: 99.92%
Catalog No. T1649Alias TDF, PMPA, GS 1278Cas No. 147127-20-6
Tenofovir (GS 1278) is an adenine analog REVERSE TRANSC-RIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B. It is used to treat HIV INFECTIONS and CHRONIC HEPATITIS B, in combination with other ANTIVIRAL AGENTS, due to the emergence of ANTIVIRAL DRUG RESISTANCE when it is used alone.
Pack SizePriceAvailabilityQuantity
5 mg$37In Stock
10 mg$50In Stock
25 mg$71In Stock
50 mg$95In Stock
100 mg$133In Stock
500 mg$336In Stock
1 mL x 10 mM (in DMSO)$46In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Tenofovir"

Select Batch
Purity:99.92%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Tenofovir (GS 1278) is an adenine analog REVERSE TRANSC-RIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B. It is used to treat HIV INFECTIONS and CHRONIC HEPATITIS B, in combination with other ANTIVIRAL AGENTS, due to the emergence of ANTIVIRAL DRUG RESISTANCE when it is used alone.
In vitro
4 μM Tenofovir completely inhibited the growth of HIVIIIB in MT-2 cells.Tenofovir inhibited hepatitis B virus (HBV) activity in HepG2 2.2.15, HepAD38 and HepAD79 cells. Tenofovir reduced the viral cytopathic effects of HIV-1(IIIB), HIV-2(ROD) and HIV(EHO) in MT-4 cells with EC50s of 1.15 μg/mL, 1.12 μg/mL, and 1.05 μg/mL.Tenofovir also reduced the viral cytopathic effects of SIV(mac251), SIV(B670), SHIV(89.6) and SHIV(89.6). Tenofovir also reduced the cytopathic effect of SIV(mac251),SIV(B670),SHIV(89.6) and SHIV(RTSHIV).Tenofovir showed unique activity against polynucleoside-resistant HIV expressing the Q151M mutation, and was less susceptible to viruses with the T69S insertion mutation.
In vivo
4 μM Tenofovir completely inhibited the growth of HIVIIIB in MT-2 cells.Tenofovir inhibited hepatitis B virus (HBV) activity in HepG2 2.2.15, HepAD38 and HepAD79 cells. Tenofovir reduced the viral cytopathic effects of HIV-1(IIIB), HIV-2(ROD) and HIV(EHO) in MT-4 cells with EC50s of 1.15 μg/mL, 1.12 μg/mL, and 1.05 μg/mL.Tenofovir also reduced the viral cytopathic effects of SIV(mac251), SIV(B670), SHIV(89.6) and SHIV(89.6). Tenofovir also reduced the cytopathic effect of SIV(mac251),SIV(B670),SHIV(89.6) and SHIV(RTSHIV).Tenofovir showed unique activity against polynucleoside-resistant HIV expressing the Q151M mutation, and was less susceptible to viruses with the T69S insertion mutation.
Cell Research
Cells are plated into 48-well tissue culture plates (39,000 cells/mL) and allowed to grow for 48 h followed by treatment with vehicle or Tenofovir. Following the treatment period, cell viability is assessed using the MTT assay. The MTT assay relies on the conversion of tetrazolium dye 3-(4,5-dimethlthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to formazan by NAD(P)H-dependent oxidoreductases[1].
AliasTDF, PMPA, GS 1278
Chemical Properties
Molecular Weight287.21
FormulaC9H14N5O4P
Cas No.147127-20-6
SmilesC[C@H](CN1C=NC2=C1N=CN=C2N)OCP(O)(O)=O
Relative Density.1.79 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 4 mg/mL (13.92 mM), Heating is recommended.
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
H2O: 2 mg/mL (6.96 mM)
Solution Preparation Table
H2O/DMSO
1mg5mg10mg50mg
1 mM3.4818 mL17.4089 mL34.8177 mL174.0886 mL
5 mM0.6964 mL3.4818 mL6.9635 mL34.8177 mL
DMSO
1mg5mg10mg50mg
10 mM0.3482 mL1.7409 mL3.4818 mL17.4089 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Tenofovir | purchase Tenofovir | Tenofovir cost | order Tenofovir | Tenofovir chemical structure | Tenofovir in vivo | Tenofovir in vitro | Tenofovir formula | Tenofovir molecular weight